COMMUNIQUÉS West-GlobeNewswire

Kiniksa Presents Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
13/05/2019
- Data strengthen the scientific evidence for targeting OSMRβ and dual pathway inhibition of IL-31 and OSM via KPL-716 for the potential treatment of chronic pruritic diseases HAMILTON, Bermuda, May 13, 2019 (GLOBE [...]
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
13/05/2019
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib in Greater China [...]
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
13/05/2019
Safety study completed; Expect to report data from 2nd pivotal Phase 3 trial by the end of second quarter 2019 NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company [...]
Unum Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
13/05/2019
- Advancing ACTR Clinical Programs in Non-Hodgkin Lymphoma, Multiple Myeloma, and HER2+ Advanced Cancers Through Dose Escalation Studies with Data Expected from All Four Ongoing Trials in Second Half of 2019 - - [...]
Microbix Reports Results for Q2 Fiscal 2019
13/05/2019
Record Sales of $4.25 Million, Sales Growth of 42%, and Material Net Earnings TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and [...]
G1 Therapeutics to Present at UBS Global Healthcare Conference
13/05/2019
RESEARCH TRIANGLE PARK, N.C., May 13, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will present [...]
Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company
13/05/2019
– Completed enrollment in Phase 2 studies of praliciguat in diabetic nephropathy and heart failure with preserved ejection fraction (HFpEF) – – Based on encouraging tolerability data, company intends to add a higher [...]
Trillium Therapeutics Reports First Quarter 2019 Financial Results
13/05/2019
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial [...]
Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare [...]
BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders
13/05/2019
BERKELEY, Calif., and VANCOUVER, British Columbia, May 13, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Catalyst Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
13/05/2019
-Firdapse® Launch Off to Strong Start with First Quarter Net Revenues of $12.4 Million -81 Patients Without Previous Access to any Form of Amifampridine Have Been Prescribed Firdapse -Company to Host Quarterly [...]
Arcoma AB Mattias Rundgren utses till Business Controller för Arcoma
13/05/2019
Arcoma AB (publ) har tillsatt Mattias Rundgren som Business Controller, from den 1:a augusti 2019. Mattias har en civilekonomexamen från Linnéuniversitetet i Växjö och en Bachelor of Arts i Theatre Arts från California [...]
Saniona forms PWS Scientific Advisory Board and provides update on ongoing study
13/05/2019
PRESS RELEASE May 13, 2019 · Scientific Advisory Board (SAB) established for Tesomet in Prader Willi Syndrome Tesomet 0.25 mg/day extension study ongoing in Czech Republic and Hungary Saniona (OMX: SANION), a biotech [...]
EssilorLuxottica: EssilorLuxottica and Delfin sign settlement agreement to solve EssilorLuxottica’s governance issues and unlock the Group’s potential to accelerate the integration process
13/05/2019
EssilorLuxottica and Delfin sign settlement agreement to solve EssilorLuxottica’s governance issues and unlock the Group’s potential to accelerate the integration process Leonardo Del Vecchio and Hubert Sagnières [...]
EssilorLuxottica :
13/05/2019
EssilorLuxottica et Delfin signent un accord pour résoudre les conflits de gouvernance d’EssilorLuxottica et accélérer le processus d’intégration du groupe Leonardo Del Vecchio et Hubert Sagnières donnent mandat à [...]
Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines
13/05/2019
Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines Promising cancer gene therapy programme using small interfering RNA (siRNA [...]
The mechanism of action of Phytoene applied to dermocosmetic now determined and promoted at the NYSCC Suppliers' day
13/05/2019
DEINOVE has developed a unique bioproduction process that leads to the first 100% pure Phytoene with an anti-aging action which mechanism of action has been discovered and reveals a target of choice in cell regeneration [...]
Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration.
13/05/2019
Amsterdam, The Netherlands – 13 May 2019 Esperite N.V. announced on 30 April 2019 that the publication of the Annual Report 2018 will be delayed. The Company has made significant progress and it is confident in its [...]
BrainStorm CEO to Present at the World Advanced Therapy and Regenerative Medicine Congress in London
13/05/2019
NEW YORK and LONDON, May 13, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( Nasdaq: BCLI ), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Chaim [...]

Pages